Results 221 to 230 of about 133,969 (353)

Phantom flowers,

openalex   +2 more sources

Improved cardiac anthropomorphic phantom. [PDF]

, 1994
Stephen W. Smith, M.P. Combs, David B. Adams, Joseph Kisslo   +3 more
openalex   +1 more source

A Novel Approach to Fabricate Early Keratoconus Phantom Models. [PDF]

Transl Vis Sci Technol
Tong H, Wu M, Han J, Li L, Zhang H.
europepmc   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Phantom Type Afterbody-Drag at Subsonic Reheat Unlit Cruise Condition

, 1971
Shigenori ANDO, Hidehiko Nishiwaki
openalex   +2 more sources

3D-Printed Organ-Realistic Phantoms to Verify Quantitative SPECT/CT Accuracy for 177Lu-PSMA-617 Treatment Planning. [PDF]

Pharmaceuticals (Basel)
Wilson LJ, Belko S, Gingold E, Wan S, Monane R, Pugliese R, Mourtada F.   +6 more
europepmc   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

IN-PHANTOM DOSIMETRY OF PROTOTYPIC PLUTONIUM CIRCULATORY SUPPORT HEAT SOURCES.

, 1972
F W Cross, J.C. Sheppard
openalex   +2 more sources

Direct 3-D printing of complex optical phantoms using dynamic filament mixing. [PDF]

Sci Rep
Ragunathan R, Mireles M, Xu E, Lewis A, Vanegas M, Fang Q.   +5 more
europepmc   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source